Company profile
Annexon Biosciences
Unlocking the Next Generation of Complement Therapies
- Industry
- Biotechnology Research
- Employees
- 114
- Headquarters
- South San Francisco, California
- Founded
- 2011
- LinkedIn followers
- 9,966
- Office locations
- 1
Annexon Biosciences company summary
Annexon Biosciences is a company in the Biotechnology Research industry, headquartered in South San Francisco, California, founded in 2011. On LinkedIn the company has around 114 employees and 9,966 followers. Its listed specialties include Neurodegeneration, Autoimmune, Ophthalmology.
What technology does Annexon Biosciences use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Annexon Biosciences
Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company’s pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration), and ANX009 (subcutaneous administration). Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio. For more information, visit www.annexonbio.com.
Specialties
Where is Annexon Biosciences located?
Annexon Biosciences lists 1 location.
Compare companies similar to Annexon Biosciences
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Annexon Biosciences annexonbio.com | Biotechnology Research | 114 | 2011 | South San Francisco, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Annexon Biosciences
What does Annexon Biosciences do?
Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company’s pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration), and ANX009 (subcutaneous administration). Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio. For more information, visit www.annexonbio.com.
How many employees does Annexon Biosciences have?
Annexon Biosciences has around 114 employees on LinkedIn.
Where is Annexon Biosciences headquartered?
Annexon Biosciences is headquartered in South San Francisco, California.
When was Annexon Biosciences founded?
Annexon Biosciences was founded in 2011.
Build a lead list from companies like Annexon Biosciences
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.